These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 34079032

  • 1. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
    Parker MM, Damrauer SM, Tcheandjieu C, Erbe D, Aldinc E, Hawkins PN, Gillmore JD, Hull LE, Lynch JA, Joseph J, Ticau S, Flynn-Carroll AO, Deaton AM, Ward LD, Assimes TL, Tsao PS, Chang KM, Rader DJ, Fitzgerald K, Vaishnaw AK, Hinkle G, Nioi P.
    Sci Rep; 2021 Jun 02; 11(1):11645. PubMed ID: 34079032
    [Abstract] [Full Text] [Related]

  • 2. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
    Damrauer SM, Chaudhary K, Cho JH, Liang LW, Argulian E, Chan L, Dobbyn A, Guerraty MA, Judy R, Kay J, Kember RL, Levin MG, Saha A, Van Vleck T, Verma SS, Weaver J, Abul-Husn NS, Baras A, Chirinos JA, Drachman B, Kenny EE, Loos RJF, Narula J, Overton J, Reid J, Ritchie M, Sirugo G, Nadkarni G, Rader DJ, Do R.
    JAMA; 2019 Dec 10; 322(22):2191-2202. PubMed ID: 31821430
    [Abstract] [Full Text] [Related]

  • 3. Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: Neurological and cardiological features.
    Gentile L, Di Bella G, Minutoli F, Cucinotta F, Obici L, Mussinelli R, Arimatea I, Russo M, Toscano A, Vita G, Mazzeo A.
    J Peripher Nerv Syst; 2020 Sep 10; 25(3):273-278. PubMed ID: 32395865
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V, Grittner U, Beetz C, Skripuletz T, Juenemann M, Krämer HH, Hahn K, Rieth A, Schaechinger V, Patten M, Tanislav C, Achenbach S, Assmus B, Knebel F, Gingele S, Skrahin A, Hartkamp J, Förster TM, Roesner S, Pereira C, Rolfs A.
    Ann Med; 2021 Dec 10; 53(1):1787-1796. PubMed ID: 34658264
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
    Arvanitis M, Koch CM, Chan GG, Torres-Arancivia C, LaValley MP, Jacobson DR, Berk JL, Connors LH, Ruberg FL.
    JAMA Cardiol; 2017 Mar 01; 2(3):305-313. PubMed ID: 28196196
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Variable Presentation of Hereditary Transthyretin-Mediated Amyloidosis at a Single Center.
    Hussain Y.
    J Clin Neuromuscul Dis; 2021 Sep 01; 23(1):7-17. PubMed ID: 34431796
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record.
    Agbor-Etang BB, Okafor HE, Farber-Eger EH, Wells QS.
    Am J Med; 2021 Feb 01; 134(2):e98-e100. PubMed ID: 32866461
    [Abstract] [Full Text] [Related]

  • 12. Clinical comparison of V122I genotypic variant of transthyretin amyloid cardiomyopathy with wild-type and other hereditary variants: a systematic review.
    Goyal A, Lahan S, Dalia T, Ranka S, Bhattad VB, Patel RR, Shah Z.
    Heart Fail Rev; 2022 May 01; 27(3):849-856. PubMed ID: 33768376
    [Abstract] [Full Text] [Related]

  • 13. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
    Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O'Hara C, Seldin DC, Skinner M.
    Am Heart J; 2009 Oct 01; 158(4):607-14. PubMed ID: 19781421
    [Abstract] [Full Text] [Related]

  • 14. Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays.
    Kaku MC, Bhadola S, Berk JL, Sanchorawala V, Connors LH, Lau KHV.
    Amyloid; 2022 Sep 01; 29(3):184-189. PubMed ID: 35253562
    [Abstract] [Full Text] [Related]

  • 15. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
    Porcari A, Razvi Y, Masi A, Patel R, Ioannou A, Rauf MU, Hutt DF, Rowczenio D, Gilbertson J, Martinez-Naharro A, Venneri L, Whelan C, Lachmann H, Wechalekar A, Quarta CC, Merlo M, Sinagra G, Hawkins PN, Fontana M, Gillmore JD.
    Eur J Heart Fail; 2023 Apr 01; 25(4):515-524. PubMed ID: 36644836
    [Abstract] [Full Text] [Related]

  • 16. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population.
    Kozlitina J, Garg S, Drazner MH, Matulevicius SA, Ayers C, Overton J, Reid J, Baras A, Rao K, Pandey A, Berry J, de Lemos JA, Grodin JL.
    J Card Fail; 2022 Mar 01; 28(3):403-414. PubMed ID: 34634447
    [Abstract] [Full Text] [Related]

  • 17. DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis.
    Akinboboye O, Shah K, Warner AL, Damy T, Taylor HA, Gollob J, Powell C, Karsten V, Vest J, Maurer MS.
    Amyloid; 2020 Dec 01; 27(4):223-230. PubMed ID: 32456532
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T, Oikawa M, Amami K, Kanno Y, Yokokawa T, Misaka T, Yamada S, Kunii H, Nakazato K, Ishida T, Takeishi Y.
    Int Heart J; 2019 Nov 30; 60(6):1441-1443. PubMed ID: 31666456
    [Abstract] [Full Text] [Related]

  • 20. Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study.
    Albenque G, Bézard M, Kharoubi M, Odouard S, Lunati A, Poullot E, Zaroui A, Teiger E, Hittinger L, Audard V, El Karoui K, Funalot B, Fanen P, Damy T, Oghina S.
    Amyloid; 2023 Dec 30; 30(4):407-415. PubMed ID: 37377439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.